MedStAR Publications

Geist ML, Radick AC, Tsui JI, Blalock KL, Adwell A, Tamru E, Connolly NC, James JR. Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study. Addict Sci Clin Pract. 2023 May 25;18(1):33. doi: 10.1186/s13722-023-00389-8. PMID: 37231486; PMCID: PMC10210339.

Mostofi N, Collins SE. Impact of Harm Reduction Treatment with or without Pharmacotherapy on Polysubstance Use among People Experiencing Homelessness and Alcohol Use Disorder. J Addict Med. 2023 Sep-Oct 01;17(5):574-579. doi: 10.1097/ADM.0000000000001182. Epub 2023 May 30. PMID: 37788612; PMCID: PMC10593979.

Altwies EE, Zinsli KA, Chwastiak L, Tsui JI, Bhatraju EP, Ramchandani MS, Golden MR, Dombrowski JC. Substance Use and Mental Health Comorbidities and Receipt of Specialty Care Among Patients Enrolled in a Low-Barrier HIV Clinic. AIDS Behav. 2023 Dec;27(12):3952-3960. doi: 10.1007/s10461-023-04110-3. Epub 2023 Jun 23. PMID: 37351687.

Katheryn Salow, Jack HE, Tinsley J, Banta-Green CJ, Kingston S, Iles-Shih M, Tsui JI, Glick S. Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys. Harm Reduct J. 2023 Sep 14;20(1):133. doi: 10.1186/s12954-023-00868-w. PMID: 37704989; PMCID: PMC10500904.

Zoë Kratina-Hathaway, Radick AC, Leroux BG, Blalock K, Kim TW, Darnton J, Saxon AJ, Samet JH, Tsui JI. Methamphetamine use and illicit opioid use during buprenorphine treatment. J Subst Use Addict Treat. 2023 Aug;151:208934. doi: 10.1016/j.josat.2022.208934. Epub 2023 Jan 6. PMID: 37811395; PMCID: PMC10554569.

Tsui JI, Daniel Stephens, Collins B, Denisiuk E, Hallgren KA, Blalock KL, Klein JW, Jack HE, Merrill JO. Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine. J Addict Med. 2023 Jul-Aug 01;17(4):491-492. doi: 10.1097/ADM.0000000000001129. Epub 2023 Jan 17. PMID: 37579119; PMCID: PMC10350466..

Jack HE, Denisiuk ED, Collins BA, Daniel Stephens, Blalock KL, Klein JW, Bhatraju EP, Merrill JO, Hallgren KA, Tsui JI. Peer providers and linkage with buprenorphine care after hospitalization: A retrospective cohort study. Subst Abus. 2022 Dec;43(1):1308-1316. doi: 10.1080/08897077.2022.2095078. PMID: 35896006; PMCID: PMC9586121.

Einberger Clare, Graupensperger S, Lee CM. Young adults’ physical distancing behaviors during the initial months of the COVID-19 pandemic: Adherence to guidelines and associations with alcohol use behavior. Emerg Adulthood. 2021 Oct;9(5):541-549. doi: 10.1177/21676968211004679. Epub 2021 Apr 5. PMID: 34900404; PMCID: PMC8664064.

Graupensperger S, Cadigan JM, Einberger Clare, Lee CM. Multifaceted COVID-19-Related Stressors and Associations with Indices of Mental Health, Well-being, and Substance Use Among Young Adults. Int J Ment Health Addict. 2023;21(1):418-431. doi: 10.1007/s11469-021-00604-0. Epub 2021 Aug 4. PMID: 34377106; PMCID: PMC8336528.

National Conference Presentations

 

Brian Lusby, Mirriam Mkhize, Tolulope Abidogun, Morgan Soraya Anvari, Yvonne Akinyi Ochieng, Jamie Darnton, Alexandra Leah Rose, Mary Buckley Kleinman, Nonceba Ciya, Bronwyn Myers-Franchi, Jessica Magidson, Helen Jack.  Peer-led Behavioral Activation: A Feasibility Analysis in Low-Resource Settings.  Association for Multidisciplinary Education and Research in Substance Use and Addication (AMERSA) conference in Washington DC, November 2023.

 

 

Megan Yerton, Connor J. McCabe, Matt Iles-Shih, Judith I. Tsui, Kevin A. Hallgren. Potential Receipt of Behavioral and Pharmacologic Treatments by Patients with Methamphetamine Use Disorder in Rural-Serving Primary Care Clinics in the Pacific Northwest. The Addiction Health Services Research (AHSR) conference, October 2023.  Poster presentation.

 

 

 

Dane Patey, Katharine Bradley, Malia Oliver, Theresa E Matson, Helen E. Jack, Douglas Berger, Tessa Steel, Amy Lee and Kevin Hallgren. The prevalence of identified unhealthy alcohol use and alcohol use disorder (AUD) when alcohol screening is conducted online versus on paper. International Network on Brief Interventions for Alcohol and Other Drugs 2023 (INEBRIA).  Oral poster presentation.

Ariana S. Gross, Olivia J. Fletcher M.Sc., Amy J. Kennedy MD MS, Emily C. Williams PhD MPH.  PrEP Awareness, Use, Willingness and Physician Engagement Across Sexually and Gender Diverse Veterans Who Use Drugs. College on Problems of Drug Dependence (CPDD) June 2023 Poster presentation.

 

Mylinh H. Le, Tanja C. Laschober, Susan Tross, Margaret Paschen-Wolff. Attitudes Toward Naloxone Uptake for Opioid Overdose Prevention Among People Who Use Opioids in the Southeastern US. College on Problems of Drug Dependence (CPDD) June 2023 Poster presentation.

Sophie C. Morse, Canada Parrish, Callan E. Fockele, Chris Craft, Sarah Leyde, Arvin R. Akhavan, Ellie Sveum, Timothy Fredrickson, Lauren Whiteside. Program Evaluation of UW Medicine’s response to Washington State Bill 5195 of Naloxone Distribution. College on Problems of Drug Dependence (CPDD) June 2023 Poster presentation.

 

Ché Ross, Judith I. Tsui, MD, Andrea Radick, Jason Deen, Dedra Buchwald, Astrid Suchy-Dicey. Prescribed Opioids and Neurocognitive Status Among American Indian Elders: Data From The Strong Heart Study.  College on Problems of Drug Dependence (CPDD) June 2023 Poster presentation.

Katheryn Salow and Sara Glick, PhD.  Disparities in Use of Syringe Services Programs in King County, WA.  College on Problems of Drug Dependence (CPDD) June 2023 Poster presentation.

Mary Geist, Andrea Radick, Judith Tsui, Kendra L. Blalock, Addy Adwell, Elsabeth Tamru, Nancy C. Connolly, Jocelyn R. James. Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study. Association for Medical Education and Research in Substance abuse Conference (AMERSA)  November 2022.Oral poster presentation

 

Chey S, Smith S, Naveed A, Bhatia N, Nguyen A, Slaughter F, Wallace S, Simoni JM, Beima-Sofie K, Graham SM. Experiences Accessing Healthcare Services among Persons Living with HIV during COVID-19 Social Distancing in Western Washington. 17th International Conference on HIV Treatment and Prevention Adherence (IAPAC), November 2022. Co-author on poster.

Anita M. Samuel, Christine M. Lee, Melissa A. Lewis, and Anne M. Fairlie. Putting Safer Drinking Into Context: Associations Between Drinking Contexts and the Use of Alcohol-Related Protective Behavioral Strategies Among College Students.  Research Society on Alcoholism (RSA), June 2022.  Dr. Fairlie presented Anita’s poster.

Nguyen AT, Slaughter F, Smith S, Katz D, Prabhu S, Tsui JI, Simoni JM, Graham SM. COVID-19 stress and increased substance use among persons living with HIV in Western Washington. 43rd Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine (SBM), April 2022. Poster presentation.

Slaughter F, Nguyen A, Micheni M, Smith S, Katz D, Prabhu S, Khosroour C, Crane H, Simoni JM, Wallace S, Graham SM. The impact of COVID-19 stress on decreased ART adherence and unsuppressed viral load among HIV clinic patients in Western Washington. 16th International Conference on HIV Treatment and Prevention Adherence (IAPAC), November 2021.  Co-author on poster.

Smith S, Naveed A, Bhatia N, Micheni M, Nguyen A, Slaughter F, Wallace S, Simoni JM, Beima-Sofie K, Graham SM. Impact of the COVID-19 pandemic on persons living with HIV in western Washington: Examining lived experiences of social distancing stress, personal buffers, and mental health. 16^th International Conference on HIV Treatment and Prevention Adherence (IAPAC), November 2021.  Co-author on poster.

Dan Stephens, Methamphetamine Use and Linkage to Outpatient Treatment for Hospitalized Patients who Initiate Buprenorphine. Addiction Health Services Research Conference (AHSR), October 2021.  Poster presentation.

Lauren Nguyen, Karl Jablonowski, Kevin Hallgren, Dawn Taniguchi, Lauren K. Whiteside.  Transition of Care From the Emergency Department for Patients With Opioid Use Disorder Who Receive Buprenorphine.  College on Problems of Drug Dependence (CPDD), June 2021.  Poster presentation.

Zoë Kratina-Hathaway, Andrea C. Radick, Zachery A. Schramm, Kendra L. Blalock, Brian G. Leroux, Theresa W. Kim, Judith I. Tsui. Baseline methamphetamine and/or amphetamine use and illicit opioid use during buprenorphine treatment. College on Problems of Drug Dependence (CPDD) June 2021 Poster presentation.

Lauren Nguyen, Karl Jablonowski, Kevin Hallgren, Dawn Taniguchi, Lauren K. Whiteside.  Transition of Care From the Emergency Department for Patients With Opioid Use Disorder Who Receive Buprenorphine. Society For Academic Emergency Medicine (SAEM), May 2021.  Poster presentation.

Einberger C, Young Adults’ Physical Distancing Behaviors During the Initial Months of the COVID-19 Pandemic: Adherence to Guidelines and Associations with Alcohol Use Behavior. Research Society on Alcohol (RSA), April 2021 Poster presentation.

Arianna P. Lee, Kevin A. Hallgren, Kendra L. Blalock, Joseph O. Merrill, Addy Adwell, Geoffrey S. Baird, Junyan Shi, Judith I. Tsui MD, Jared W. Klein.  Less Intensive Urine Drug Screening in Buprenorphine Treatment.  American Society of Addiction Medicine (ASAM), April 2021.  Poster presentation.

Accolades

Zoe Kratina-Hathaway receives Margaret O’Donnell Prize in Psychiatry.  This prize is awarded to a senior medical student who has been highly involved in behavioral health issues and outstanding academic work in psychiatry. As a medical student she was the co-leader and coordinator for the Mental Health Clinic in Boseman, MT. This student-run volunteer clinic provides psychiatric care for patients unable to afford mental health services. She also was a co-lead for the Psychiatric Interest Group and has extensive involvement in substance use disorder research including a four-year long NIH funded Medical Student Addictions Research program.